approved

IDEX Biometrics – Approved Prospectus – 13 Nov 2024

Reference is made to the stock exchange announcement issued by IDEX Biometrics ASA (the “Company”) on 17 September 2024 regarding…

1 week ago

ALK licenses rights to neffy, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)

ALK (ALKB:DC / OMX: ALK B) today announced that it has entered into a strategic license agreement with US-based ARS…

1 week ago

ALK licenses rights to neffy, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)

ALK (ALKB:DC / OMX: ALK B) today announced that it has entered into a strategic license agreement with US-based ARS…

2 weeks ago